The Frustration of Ovarian Cancer: A Silent Killer or a Missed Diagnosis
Ovarian cancer is often detected at advanced stages, making treatment challenging. Experts emphasize the need for early detection and awareness of symptoms to improve prognosis.
Ovarian cancer is a significant concern for women, with three out of four cases detected at advanced stages. The disease often grows in the abdominal cavity without showing evident symptoms, making it difficult to diagnose early. María, a 51-year-old woman, was recently diagnosed with ovarian cancer in stage III. She experienced a sensation of weight in her pelvic area after a long walk, which led her to consult a doctor. An ultrasound revealed the disease.
The Challenge of Early Detection
The lack of specific symptoms and effective screening methods makes early detection of ovarian cancer a significant challenge. According to Gemma Mancebo, head of Gynecology and Obstetrics at Hospital del Mar, the tumor can grow in the abdomen without interfering with other organs, causing vague symptoms like bloating, early satiety, or abdominal discomfort. These symptoms are often attributed to other conditions, delaying diagnosis.
The Myth of the Silent Killer
The notion that ovarian cancer is a "silent killer" is disputed by experts. Elizabeth Comen, an oncologist, argues that the disease is not silent but rather ignored. A study found that 95% of patients reported noticeable symptoms between three and 12 months before diagnosis. However, these symptoms were often misattributed to other conditions, such as irritable bowel syndrome, stress, or gastritis.
Treatment and Prognosis
While there is no effective screening method for ovarian cancer, treatment options are available. Surgery, chemotherapy, and targeted therapies can help manage the disease. According to Antonio González, director of the Department of Medical Oncology at Clínica Universidad de Navarra, the goal is to detect the disease early and provide timely treatment. The estimated five-year survival rate for ovarian cancer is around 40%. Experts emphasize the need for awareness and education to improve prognosis and survival rates.
| Category | Estimated New Cases 2026 | Five-Year Survival Rate |
|---|---|---|
| Ovarian Cancer | 3,700 | 40% |
| Breast Cancer | 38,000 | - |
The development of new treatments and therapies is ongoing, with a focus on targeted therapies and immunotherapy. Experts hope that advances in these areas will improve prognosis and survival rates for ovarian cancer patients. As María prepares to undergo chemotherapy, she remains hopeful about her treatment and the possibility of managing her disease.
